Microfluidic Immunoassay Market By Product Type, By Technology, By Application and By Region: Industry Analysis, Market Share, Revenue Opportunity, Competitive Analysis and Forecast 2026-2036
According to FutureWise analysis, the microfluidic immunoassay market in 2026 is US$1.86 billion, and is expected to reach US$4.71 billion by 2036 at a CAGR of 9.74%.
The microfluidic immunoassay market is currently experiencing notable growth, primarily driven by the rising demand for point-of-care diagnostics and an increase in chronic disease cases that require swift testing solutions. Technological advancements, particularly in lab-on-a-chip devices and miniaturization techniques, are leading to the creation of more accurate and cost-effective diagnostic platforms. As it stands, North America dominates the market share, with Europe and the Asia-Pacific region following. The latter, in particular, is witnessing faster adoption rates in emerging markets. Key applications in this sector include testing for infectious diseases, the detection of cancer biomarkers, and cardiovascular diagnostics. The ongoing shift toward personalized medicine and a growing inclination toward home-based testing, especially in the wake of the pandemic, are additional factors driving market expansion. Recent developments in microfluidic technology have captured significant attention, mainly due to the integration of entire laboratory processes onto a single chip, thereby reducing the need for separate instruments. Microfluidic systems have demonstrated promising outcomes in the realm of immunosensors. These sensors offer considerable advantages over traditional methods, including a high surface-to-volume ratio that facilitates efficient mass transport in immunoreactions. Given these advancements and the increasing prevalence of various diseases, the market is expected to experience substantial growth during the forecast period.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Microfluidic Immunoassay Market trends that shall affect the overall market growth.

Request a Free Sample @
https://www.futurewiseresearch.com/contact.aspx?rpt=8935&type=requestsample

By Product Type
• Lab-on-chip/microfluidic diagnostics
o Microfluidic Analyzers
o MicrofluidicCartridges
• Other Quantifiable POC diagnostics
o POC Analyzers
o Reagents and Assays
By Technology
• Point of Care Lab on Chip Technology
o Electrochemical LOC POC Technology
o Optical POC LOC Technology
• Non Lab on Chip Point of Care Technology
By Application
• Cardiac Biomarker Detection
o Single Biomarker Assay
o Troponin
o Brain Natriuretic Peptide (BNP)
o Other Cardiac Biomarkers
o Multiplexed Panel Assay
• Inflammatory Biomarker Detection
• Other Biomarkers
• Emerging Biomarkers
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape in Microfluidic Immunoassay Market :
• Abaxis, Inc. (a subsidiary of Zoetis Inc.)
• Nanomix, Inc.
• Abbott Laboratories
• Koninklijke Philips N.V.
• Biosurfit SA
• Micropoint science, Inc.
• Siloam Biosciences
• NanoEnTek Inc.
• OPKO Health, Inc.
• Quidel Corporation

Buy now the latest version of this report:
https://www.futurewiseresearch.com/checkout.aspx?ReportId=8935&license=multi

**Objectives of this Study: **
1. To provide a comprehensive analysis of the Microfluidic Immunoassay Market By Product Type, By Technology, By Application and By Region.
2. To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
3. To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
4. To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
• The customization services offered are free of charge with the purchase of any license of the report.
• You can directly share your requirements/changes to the current table of contents to: [email protected]

FutureWise Research
Contact Person: Vinay Thaploo.
Email: [email protected]
Contact Number: Asia: +91 8605575209 | UK: +44 0113 519 7222
Website: www.futurewiseresearch.com